Package 69238-1165-7

Brand: abiraterone acetate

Generic: abiraterone
NDC Package

Package Facts

Identity

Package NDC 69238-1165-7
Digits Only 6923811657
Product NDC 69238-1165
Description

120 TABLET in 1 BOTTLE (69238-1165-7)

Marketing

Marketing Status
Marketed Since 2019-01-07
Brand abiraterone acetate
Generic abiraterone
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c03e6ebe-681b-40c0-b123-741dd35fd558", "openfda": {"upc": ["0369238116571", "0369238175462"], "unii": ["EM5OCB9YJ6"], "rxcui": ["1100075", "1918042"], "spl_set_id": ["c9eb9b46-f847-40a8-802c-a51b40406d5a"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (69238-1165-7)", "package_ndc": "69238-1165-7", "marketing_start_date": "20190107"}], "brand_name": "Abiraterone Acetate", "product_id": "69238-1165_c03e6ebe-681b-40c0-b123-741dd35fd558", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 17A1 Inhibitor [EPC]", "Cytochrome P450 17A1 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]"], "product_ndc": "69238-1165", "generic_name": "Abiraterone", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abiraterone Acetate", "active_ingredients": [{"name": "ABIRATERONE ACETATE", "strength": "250 mg/1"}], "application_number": "ANDA208327", "marketing_category": "ANDA", "marketing_start_date": "20190107", "listing_expiration_date": "20261231"}